4//SEC Filing
Kalin Katherine Bach 4
Accession 0001104659-22-091751
CIK 0001390478other
Filed
Aug 15, 8:00 PM ET
Accepted
Aug 16, 4:08 PM ET
Size
5.5 KB
Accession
0001104659-22-091751
Insider Transaction Report
Form 4
Kalin Katherine Bach
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-08-13+19,000→ 19,000 totalExercise: $3.10Exp: 2032-08-13→ Common Stock (19,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option will fully vest on August 13, 2023.
Documents
Issuer
SELLAS Life Sciences Group, Inc.
CIK 0001390478
Entity typeother
Related Parties
1- filerCIK 0001832671
Filing Metadata
- Form type
- 4
- Filed
- Aug 15, 8:00 PM ET
- Accepted
- Aug 16, 4:08 PM ET
- Size
- 5.5 KB